Has Asia Lo, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $21,022 in general payments to Asia Lo, DPM across 318 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Asia Lo, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Asia Lo, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Asia Lo, DPM

Foot & Ankle Surgery · Houston, TXNPI 1386625812

Payments from drug & device makers

$21,022in general payments, 2019–2025

Across 318 payments — averaging $66.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Kerecis Limited$4K
Stryker$3K
Trimed, Inc.$3K
ETS Wound Care LLC$2K
Biotissue Holdings Inc.$2K
Smith+Nephew$1K
plus $7K from 46 others

What the payments were for

Consulting fees$1000%
Speaking & faculty fees$1,5007%
Travel & lodging$5,72227%
Food & beverage$12,98662%
Education$6783%
Gifts$360%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Kerecis Limited	13	$4,137
Stryker(2 entities)	40	$2,966
Trimed, Inc.	17	$2,787
ETS Wound Care LLC	11	$1,841
Biotissue Holdings Inc.	8	$1,514
Smith+Nephew	61	$1,266
Treace Medical Concepts, Inc.	17	$1,155
AbbVie	19	$496
Reddress USA, Inc.	3	$404
Medshape, Inc.	7	$375
Trilliant Surgical LLC.	5	$272
Medline Industries LP	7	$232
Musculoskeletal Transplant Foundation Inc.	4	$230
Melinta Therapeutics, LLC	10	$191
Mimedx Group, Inc.	6	$179
Paratek Pharmaceuticals, Inc.	10	$178
Organogenesis Inc.	3	$170
Medtronic	3	$169
Osiris Therapeutics Inc.	3	$169
Bone Support Inc.	2	$165
In2bones USA, LLC	1	$154
Bioventus LLC	5	$150
Restor3d, Inc.	2	$145
Hartmann USA, Inc.	6	$136
Axogen	1	$126
Veryan Medical Incorporated	1	$122
Alafair Biosciences, Inc.	3	$113
Comsort, Inc	1	$100
Aroa Biosurgery Incorporated	4	$87
Integra Lifesciences Corporation	3	$83
Linvatec Corporation	2	$69
GRT US Holding, Inc.	3	$69
Cardiovascular Systems Inc.	1	$67
Fusion Orthopedics USA, LLC	1	$64
Convatec Inc.	3	$52
Polynovo North America LLC	1	$47
Paragon 28, Inc.	2	$47
Solventum Corporation	2	$45
Coloplast	2	$45
Abbott	2	$44
Amgen(2 entities)	3	$44
Urgo Medical North America, LLC	2	$43
Merck	7	$42
Globus Medical	1	$38
KCI USA, Inc.	2	$33
Nevro Corp.	2	$32
ANI Pharmaceuticals, Inc.	1	$30
Acera Surgical, Inc.	1	$28
OVIK Health, LLC	1	$21
Nabriva Therapeutics, PLC	1	$21
Zimmer Biomet	1	$17
Next Science LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,022 in reported general payments places this provider in the 80th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$128,094

Medicare patients

226

Services billed

1,770

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ciclopirox	34	$808
Ammonium Lactate	36	$719
Clotrimazole	32	$416
Terbinafine Hcl	14	$108
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	12	$48
Levofloxacin	16	$47

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Houston

Kevin VarnerHouston$1.1M
Sherman NaglerHouston$602K
Abdul NurudeenHouston$404K
Orlando RiveraHouston$384K
Brian LepowHouston$311K
William GranberryHouston$155K
Yueh LeeHouston$95K
Julie LesterHouston$94K
Jason AhueroHouston$76K
Nathaniel AlabiHouston$71K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →